Obesity is not just a matter of diet, as it can be influenced by conditions such as hypothyroidism, polycystic ovary syndrome (PCOS), insulin resistance, or Cushings syndrome
Medical literature and post-marketing data have raised concerns about gastrointestinal complications, particularly when these drugs are used long term
Jolanda van Hal November in review: GLP-1 breakthroughs, UPFs under fire, Novonesis advances healthy longevity Jolanda van Hal Key takeaways GLP-1 science, product pipelines, and consumer acceptance reached a pivotal point in November, reshaping nutrition, pharma, and metabolic health
Loomba R et al., SYNERGY-NASH, NEJM 2024 (NEJMoa2401943, PMID 38856224) : tirzepatide and MASH, resolution in 62% at the 15 mg level
And the only way to work, to get it to work, is if you put in the work." Beyond physical changes, she values the mental benefits: "It has helped so much with the food noise to the point where I don't feel like I'm obsessing about food or feeling consumed by thoughts of it
13-16 weeks : After assessment, your doctor will escalate the dosage to 8 mg once weekly for the next 4 weeks 17-21 weeks : If your body tolerates 8 mg for 4 weeks, your doctor will increase the dose to 12 mg once weekly onwards